Alumni

Alumni
Biologics are protein-based antibody drugs used to treat cancers, autoimmune disorders,
Alumni
Antibody therapeutics for the immune synapse.
Alumni
QuickFire
Challenge Winner
Cyteir is revolutionizing the concept of DNA damage and repair. Conventional therapies
Alumni
Dragonfly Therapeutics develops novel first-in-class therapeutics targeted at Natural
Alumni
HiFiBiO SAS commercializes proprietary single cell technologies for applications in drug
Alumni
A powerful therapeutic approach targeting the central regulator of nutrient signaling,
Alumni
Developing next-generation cell and gene therapeutics that employ precise exogenous
Alumni
QuickFire
Challenge Winner
Riparian is discovering novel therapeutics to reduce vascular inflammation and treat
Alumni
Vedanta was founded by PureTech Ventures and a team of world renowned experts in
Alumni
QuickFire
Challenge Winner
XTuit Pharmaceuticals is pursuing novel approaches to improving cancer therapy by